U.S. flag

An official website of the United States government

Filters

See more specimen types...
See more states

Other countries

See more countries

Results: 1 to 20 of 200

Tests names and labsConditionsGenes, analytes, and microbesMethods

Lung Cancer Driver Profile

GoPath Laboratories, LLC
United States
13
  • I Immunohistochemistry
  • F Fluorescence in situ hybridization (FISH)
  • D Deletion/duplication analysis

KRAS Mutation Analysis

PathGroup
United States
131
  • T Targeted variant analysis

Cancer Hotspot Panel

Genome-Nilou Lab
Iran
4534
  • E Sequence analysis of select exons

Endeavor

PathGroup
United States
73505
  • C Sequence analysis of the entire coding region

Inherited Bone Marrow Failure Panel

PreventionGenetics
United States
230140
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Autism Spectrum Disorders (ASD) Panel

PreventionGenetics
United States
224170
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

TumorNext®-Lynch+BRCANext-Expanded™

Ambry Genetics
United States
9526
  • D Deletion/duplication analysis
  • M Methylation analysis
  • C Sequence analysis of the entire coding region

Lung Cancer Expanded Profile

GoPath Laboratories, LLC
United States
11
  • I Immunohistochemistry
  • F Fluorescence in situ hybridization (FISH)
  • E Sequence analysis of select exons

FusionPlex Solid Tumor Panel

Clinical Genomics Laboratory Laboratory for Precision Diagnostics, University of Washington
United States
3114
  • R RNA analysis

Lung cancer, protection against, 211980, Autosomal recessive (CASP8 gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Genetic Diagnosis and Research Centre
Turkey
11
  • C Sequence analysis of the entire coding region

Lung cancer, 211980, Autosomal recessive (Squamous cell carcinoma of esophagus) (DLEC1 gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Genetic Diagnosis and Research Centre
Turkey
11
  • C Sequence analysis of the entire coding region

Lung cancer, 211980, Autosomal recessive (PPP2R1B gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Genetic Diagnosis and Research Centre
Turkey
11
  • C Sequence analysis of the entire coding region

Lung cancer, 211980, Autosomal recessive (RASSF1 gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Genetic Diagnosis and Research Centre
Turkey
11
  • C Sequence analysis of the entire coding region

Lung cancer, somatic, 211980 (KRAS gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Genetic Diagnosis and Research Centre
Turkey
11
  • C Sequence analysis of the entire coding region

Lung cancer, susceptibility to, 211980, Autosomal recessive (ERCC6 gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Genetic Diagnosis and Research Centre
Turkey
11
  • C Sequence analysis of the entire coding region

Lung cancer, resistance to, 211980, Autosomal recessive (MLPA)

Intergen Genetic Diagnosis and Research Centre
Turkey
11
  • D Deletion/duplication analysis

Lung cancer, somatic, 211980 (MAP3K8 gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Genetic Diagnosis and Research Centre
Turkey
11
  • C Sequence analysis of the entire coding region

Lung cancer, resistance to, 211980, Autosomal recessive (CYP2A6 gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Genetic Diagnosis and Research Centre
Turkey
11
  • C Sequence analysis of the entire coding region

Lung cancer, susceptibility to, 211980, Autosomal recessive (FASLG gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Genetic Diagnosis and Research Centre
Turkey
11
  • C Sequence analysis of the entire coding region

Lung cancer, somatic, 211980 (SLC22A18 gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Genetic Diagnosis and Research Centre
Turkey
11
  • C Sequence analysis of the entire coding region

Results: 1 to 20 of 200

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.